Literature DB >> 11585637

The effects of calpain inhibition upon IL-2 and CD25 expression in human peripheral blood mononuclear cells.

K E Schaecher1, J M Goust, N L Banik.   

Abstract

Calcium is an important contributor to T cell activation; it is also the major factor in the activation of the calcium-activated neutral proteinase, calpain. For this reason, we wanted to investigate if calpain has a role in T cell activation and what aspects of this activation calpain affects. As measured by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), calpain inhibition decreased interleukin-2 (IL-2) and CD25 mRNA expression in a dose-dependent manner, at early time points following the initial activation, and over extended periods of time in activated human peripheral blood mononuclear cells (PBMCs). Using an enzyme-linked immuno-sorbent assay (ELISA) specific for human IL-2, we found that calpain inhibition decreased IL-2 secretion in a dose-dependent manner, shortly after activation, and continuously over time. Inhibiting calpain caused a dose-dependent inhibition of CD25 cell surface expression and also inhibited expression shortly after activation and for at least 48 h. This study showed that calpain has an integral role in the synthesis of the two important T cell activation factors, IL-2 and CD25.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585637     DOI: 10.1016/s0165-5728(01)00367-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites.

Authors:  Kurt Schaecher; Jean-Michel Goust; Naren L Banik
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

2.  Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.

Authors:  M Kelly Guyton; Arabinda Das; Supriti Samantaray; Gerald C Wallace; Jonathan T Butler; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

3.  Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.

Authors:  Sarah A Imam; Mary K Guyton; Azizul Haque; Arthur Vandenbark; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

4.  Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells.

Authors:  Mary K Guyton; Saurav Brahmachari; Arabinda Das; Supriti Samantaray; Jun Inoue; Mitsuyoshi Azuma; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

5.  Involvement of calpain in the process of Jurkat T cell chemotaxis.

Authors:  Jonathan T Butler; Supriti Samantaray; Craig C Beeson; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

6.  Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.

Authors:  Azizul Haque; Supriti Samantaray; Varduhi H Knaryan; Mollie Capone; Azim Hossain; Denise Matzelle; Raghavendar Chandran; Donald C Shields; Ariana Q Farrand; Heather A Boger; Naren L Banik
Journal:  Exp Neurol       Date:  2020-04-14       Impact factor: 5.330

7.  Roles of calpain-calpastatin system (CCS) in human T cell activation.

Authors:  Anna Mikosik; Aleksandra Jasiulewicz; Agnieszka Daca; Izabella Henc; Joanna E Frąckowiak; Katarzyna Ruckemann-Dziurdzińska; Jerzy Foerster; Aurelie Le Page; Ewa Bryl; Tamas Fulop; Jacek M Witkowski
Journal:  Oncotarget       Date:  2016-11-22

Review 8.  Proteolysis dysfunction in the process of aging and age-related diseases.

Authors:  Natalia Frankowska; Katarzyna Lisowska; Jacek M Witkowski
Journal:  Front Aging       Date:  2022-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.